Hormone replacement therapy (HRT) does protect bone: by restoring estrogen after menopause, it slows the rapid bone loss that follows and lowers the risk of spine and hip fractures. It is not usually the first drug chosen for osteoporosis on its own, though. HRT fits best for women under 60, or within about ten years of their last period, who also have troublesome menopausal symptoms. For them, one treatment can handle both problems.
Below I cover how estrogen protects the skeleton, who is a good candidate, the risks worth weighing, how HRT compares with other osteoporosis medicines, and where research is heading.
Why Menopause Accelerates Bone Loss
Bone is living tissue that is constantly being remodeled. Osteoclasts break old bone down and osteoblasts lay new bone down. In healthy adults the two processes stay roughly in balance.
Estrogen is one of the main brakes on osteoclast activity. When estrogen levels fall at menopause, osteoclasts live longer and work harder, so bone is removed faster than it can be replaced. Bone loss is fastest in the first several years after menopause, especially in the spongy trabecular bone of the spine and wrist. For a deeper look at this imbalance, see our article on the pathophysiology of osteoporosis.
Other risk factors add to the hormonal effect. These include a family history of hip fracture, low body weight, smoking, heavy alcohol use, low calcium and vitamin D intake, inactivity, and long-term glucocorticoid (steroid) medication.
How HRT Works for Osteoporosis
HRT replaces the estrogen the ovaries no longer make. Women who still have a uterus also need a progestogen, either cyclically or continuously, because estrogen alone thickens the uterine lining and raises the risk of endometrial cancer. Women who have had a hysterectomy can usually take estrogen alone.
Once estrogen is back, osteoclast activity slows, bone turnover returns toward premenopausal levels, and bone mineral density (BMD) stabilizes or rises a little. Large randomized trials have shown fewer vertebral, hip, and other fractures in women taking HRT. The protection fades once treatment stops, and bone loss resumes at roughly the menopausal rate. That is why stopping HRT should prompt a conversation about what comes next for the bones.
Forms of HRT
- Oral tablets: convenient, but they pass through the liver first, which raises clotting factors.
- Transdermal patches, gels, or sprays: skip the first pass through the liver and carry a lower risk of blood clots than tablets.
- Vaginal estrogen: treats local dryness but gives too little estrogen to the rest of the body to protect bone.
- Tibolone and tissue-selective estrogen complexes: alternatives available in some countries that act on bone while limiting stimulation of the breast or uterus.
Diagnosis: Confirming Osteoporosis Before Treatment
Osteoporosis is often called a silent disease because nothing hurts until a bone breaks. Warning signs include a fracture from a minor fall, loss of height, or a stooped upper back (kyphosis).
The standard test is a DEXA scan (dual-energy X-ray absorptiometry). It measures BMD at the hip and spine and reports a T-score, which compares your bone density with that of a healthy young adult.
| T-score | Category | What it usually means |
|---|---|---|
| -1.0 or higher | Normal | Routine prevention: diet, exercise, fall avoidance |
| Between -1.0 and -2.5 | Low bone mass (osteopenia) | Treatment depends on overall fracture risk |
| -2.5 or lower | Osteoporosis | Drug treatment is generally recommended |
| -2.5 or lower plus a fragility fracture | Severe osteoporosis | Stronger or bone-building treatment is often considered |
Blood tests help rule out secondary causes before treatment starts. These typically include calcium, vitamin D, kidney and liver function, thyroid function, and sometimes parathyroid hormone. Many clinicians also use a fracture-risk calculator such as FRAX, which combines age, BMD, and risk factors into a ten-year estimate.
Benefits and Risks: Who Is a Good Candidate?
How HRT’s risks weigh against its benefits depends heavily on age and on how long it has been since menopause. Starting HRT in the early postmenopausal years carries a more favorable profile than starting it at 65 or 70.
Benefits
- Fewer spine and hip fractures while treatment continues.
- Relief of hot flushes, night sweats, sleep disruption, and vaginal dryness.
- Particularly useful after premature or early menopause (before 40 or 45), where HRT is generally advised until the natural age of menopause to protect bone and heart.
Risks
- Venous thromboembolism (blood clots in the legs or lungs), mainly with oral estrogen.
- A small increase in stroke risk, again mainly with oral forms and in older women.
- A small rise in breast cancer risk with combined estrogen-progestogen therapy that grows with longer use.
- Gallbladder disease.
HRT is generally avoided in women with a history of breast cancer, estrogen-sensitive tumors, previous blood clots, stroke, active liver disease, or unexplained vaginal bleeding. With a history of clots, a hematology opinion is worthwhile before anyone considers hormones.
How HRT Compares With Other Osteoporosis Treatments
For women who don’t need symptom relief, other drugs are usually preferred for bone alone. Calcium and vitamin D underpin all of them; our guide on supplements in osteoporosis management covers doses and pitfalls.
| Treatment | How it works | Typical role |
|---|---|---|
| HRT (estrogen ± progestogen) | Reduces bone resorption | Younger postmenopausal women with symptoms |
| Bisphosphonates (alendronate, risedronate, zoledronic acid) | Bind bone and inhibit osteoclasts | Usual first-line therapy |
| Raloxifene (a SERM) | Estrogen-like effect on bone, blocks estrogen in breast | Spine protection; lowers breast cancer risk |
| Denosumab | Antibody that blocks RANKL, a signal osteoclasts need | Injection every six months; must not be stopped abruptly |
| Teriparatide, abaloparatide | Parathyroid hormone analogues that build bone | Severe osteoporosis or very high fracture risk |
| Romosozumab | Blocks sclerostin; builds bone and reduces resorption | Very high risk, for a limited course |
Fractures themselves can cause lasting back pain. Managing that pain is part of treatment, and our article on osteoporosis pain treatment covers it in detail.
Emerging Research in HRT and Bone Health
Research in this area is moving on several fronts:
- Timing: the idea that benefits outweigh risks when HRT starts near menopause (the “timing hypothesis”) has reshaped prescribing toward earlier, individualized use.
- Safer formulations: transdermal estradiol and body-identical micronized progesterone are increasingly favored because they appear to carry lower clot and breast risks than older combinations.
- Sequential therapy: for very high-risk patients, starting with a bone-building drug and then switching to an antiresorptive such as a bisphosphonate gives larger BMD gains than the reverse order.
- Transition planning: studies are clarifying how best to protect bone when HRT stops, often by moving to a bisphosphonate.
- Genetics: gene variants that influence BMD may one day help predict who benefits most from each therapy, though this is not yet routine practice.
For an overview of every aspect of bone loss, visit our osteoporosis guide.
Key Takeaways
- HRT prevents bone loss and reduces fractures, but only while you take it.
- It suits women under 60 or within ten years of menopause, especially those with menopausal symptoms or early menopause.
- Transdermal estrogen carries a lower clot risk than tablets; women with a uterus need a progestogen.
- For bone protection alone, bisphosphonates are usually first-line.
- Plan the next step for your bones before stopping HRT.
Frequently Asked Questions
Can HRT reverse osteoporosis?
HRT mainly halts bone loss and can produce modest gains in bone density. It won’t fully rebuild bone that has already been lost. For women with severe osteoporosis, bone-building drugs such as teriparatide or romosozumab increase density more.
How long can I stay on HRT for bone protection?
There is no fixed cut-off. The decision is reviewed at least yearly and weighs symptoms, fracture risk, and personal risk factors. Many women take it for several years; if bone risk is still high when HRT stops, another bone medicine is usually started.
Is HRT safe if I have had a blood clot?
A past clot is a major caution. Oral estrogen is generally avoided, and even transdermal forms need specialist review. Non-hormonal bone treatments are usually the safer choice.
Do I still need calcium and vitamin D on HRT?
Yes. Estrogen works best when the body has enough building blocks. Most adults need adequate dietary calcium and sufficient vitamin D, and supplements fill any gap.
